Support for Allergy Research and Initiatives
In response to the allergy crisis, the Federal Government has committed an additional $14.6 million over the next two years. This allergy crisis funding aims to support research and public health programmes benefiting the eight million Australians living with allergic diseases. The funding will boost the National Allergy Centre of Excellence (NACE) and the National Allergy Council (NAC) until June 2028, as detailed in the 2025-2026 Mid-Year Economic and Fiscal Outlook (MYEFO). This investment emphasises the need for enhanced research, education, and training initiatives to combat the growing allergy issue.
Professor Kirsten Perrett, Director of NACE, highlighted the urgency, stating, “There is no cure and no time to waste when it comes to allergies, which touch almost every family, school, and healthcare service.” The funding supports efforts to fast-track Australia’s evidence-based response to the widespread chronic condition through rigorous evaluation and rapid translation of emerging evidence into clinical care.
Impact of Allergic Diseases Allergic diseases
Affect 8.2 million Australians and impose a staggering $18.9 billion annual cost on the economy, according to a Deloitte Access Economics report. The economic and social burden underscores the importance of life-changing national research infrastructure. Established in 2022, NACE and NAC have trained thousands in anaphylaxis management and food safety, and provided support through a national helpline.
Dr. Sandra Vale, CEO of NAC, expressed gratitude for the government’s support, stating, “This funding will directly support our work in delivering accessible, nationally standardised care that can save lives and reduce the burden of allergic disease.” The next phase of initiatives includes expanding research programs, enhancing public education, and improving support for those affected by allergies. A collaboration between NACE and NAC, in partnership with the Australasian Society of Clinical Immunology and Allergy (ASCIA) and Allergy & Anaphylaxis Australia, ensures that Australia remains at the forefront of allergy research and management.
Allergies present significant physical and emotional challenges, with increasing cases of anaphylaxis and, though rare, fatalities. Families seek greater community support and evidence-based information on best-practice management and emerging treatments like oral immunotherapy. Related Articles
- RACGP Urges Free MenB and Intranasal Vaccines
- Pill Testing Groups Censored by Meta and TikTok
- Australia Announces New Comprehensive Gambling Reforms for 2027
Last updated: 10 April 2026, 12:24 pm
